Agape ATP Corporation, an investment holding company ... AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Agreements to drive clinical research, enhance product safety, and combat respiratory diseases KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 29, 2024 /NASDAQ-listed AGAPE ATP Corporation ("ATPC ...
DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate Dehydrogenase Complex Deficiency ... leads to decreased ATP production and energy ...